By Notice dated October 16, 2009, and published in the Federal Register on October 28, 2009, (74 FR 55586), Lin Zhi International Inc., 687 North Pastoria Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
|3,4-Methylenedioxymethamphetamine (MDMA) (7405)||I|
|Dextropropoxyphene, bulk (non-dosage forms) (9273)||II|
The company plans to manufacture the listed controlled substances as bulk reagents for use in drug abuse testing.
No comments or objections have been received. DEA has considered the factors in 21 USC 823(a) and determined that the registration of Lin Zhi International Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Lin Zhi International Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 USC 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.Start Signature
Dated: February 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 2010-4719 Filed 3-4-10; 8:45 am]
BILLING CODE 4410-09-P